Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial

Nicholas I. Paton, Joseph Musaazi, Cissy Kityo, +100

The Lancet HIV

Barriers to implementing antimicrobial stewardship programs in three low- and middle-income country tertiary care settings: findings from a multi-site qualitative study

Robert Rolfe, Charles Kwobah, Florida Muro, +17

Antimicrobial Resistance and Infection Control

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

Nicholas I. Paton, Cissy Kityo, Immaculate Nankya, +286

The Lancet HIV

Factors Associated with First-Line Antiretroviral Therapy Failure amongst HIV-Infected African Patients: A Case-Control Study

Charles Kwobah, Ann Mwangi, Julius Koech, +2

World Journal of AIDS

ImmunodeficienciesPopulation Health SciencesWestern KenyaCase-control StudyLogistic Analysis +22

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé, +263

The Lancet Infectious Diseases

Point-prevalence survey of antibiotic use at three public referral hospitals in Kenya

Sylvia Omulo, Margaret Oluka, Loice Achieng, +18

PLoS ONE

Public Referral HospitalsPreventive MedicineAntimicrobial StewardshipHealthcare-associated InfectionInfection Control +16

Factors Associated with Late Engagement to HIV Care in Western Kenya

Charles Kwobah, Paula Braitstein, Julius Koech, +4

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Sickle Cell Disease and HIV

Esther Brenda Odera, Charles Kwobah, Geren S. Stone, +2

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Primary ImmunodeficiencySickle Cell DiseasePediatric EpidemiologyPediatric HematologyImmunodeficiencies +10

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

Cissy Kityo, David Dunn, Anne Hoppé, +282

Clinical Infectious Diseases

Human Immunodeficiency Virus and Leprosy Coinfection: Challenges in Resource-Limited Setups

Charles Kwobah, Kara Wools‐Kaloustian, Jane Gitau, +1

Case Reports in Medicine

VaccinationHiv CoinfectionCase ReportTreatment And PreventionHuman Retrovirus +12